Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
50.9KEstimate Value
N/A
#maskargo
#malaysia airlines cargo tracking
#mh cargo tracking
#malaysian airline cargo tracking
#malaysian airlines cargo tracking
#isf filing
#ams shipping
#ams fee
#ams system
#ams filing
#duty drawback
#tradeweb live
Category
N/AGlobal Rank
N/ARank in 1 month
24.1KEstimate Value
N/Acoherent is a leading global supplier of lasers and photonics technology used in a wide range of materials processing, scientific and other applications.
#lasers
#applications
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#coherent ui
#chromium embedded framework
#coherent gt
#coherent labs
#adobe animate
#unreal register functino for next tick
#hakyll
#ue4 "soft reference"
#vim airline vs powerline
#unreal .umap not visible in content folder
#unreal click to move
#unreal perforce tutorial
#click to move unreal engine 4
#ue4 shooter game
#skookumscript
#skookum script
#ue5 scripting language
#project point to navigation outside of nav mesh
#unreal scripting
#tom looman
#unreal engine 4 stealth game tutorial
#unreal engine tutorial
#unreal tutorials
Category
N/AGlobal Rank
N/ARank in 1 month
11KEstimate Value
N/A
#coherent
#coherent insurance
#product factory
#john brisco
#cohorent
#coherent solutions
#quantifi photonics
#coherent receiver
#steve warntjes
#xero limitations
#xero worldpay integration
#loading deck
#xero developer
#netlify gzip
#coworking space name ideas
#collaboration space names
#workspace names
#coworking space names
#techops
#python iot
#continuous integration
#coherant
#川上さくら
Category
Jobs and EmploymentGlobal Rank
N/ARank in 1 month
51.6KEstimate Value
N/A
Category
HealthGlobal Rank
N/ARank in 1 month
8.7KEstimate Value
N/A
#micro-mobility charging infrastructure market
#surgical retractors market
#blood ketone meter market
#vegetable parchment paper market
Malware Scan Info
Macafee Check :
Email address with coherus.com
Recent Searched Sites
Fleet-tech.com (6 seconds ago) / US
Byjolie.vn (8 seconds ago) / VN
Traceelliot.com (20 seconds ago) / US
Andersonlawncare.com (0 seconds ago) / US
Coherus.com (0 seconds ago) / US
Parents.nianticlabs.com (10 seconds ago) / US
Fkie.fraunhofer.de (0 seconds ago) / DE
Masterofmalt.com (2 seconds ago) / US
Kasandra.ua (7 seconds ago) / FR
Urologo-genova.it (5 seconds ago) / RO
Zakreconemotki.com (8 seconds ago) / PL
Enseignons.be (15 seconds ago) / FR
Mattsblackboard.com (31 seconds ago) / CA
Eng.m.x1x.com (13 seconds ago) / US
Pacesemi.org (35 seconds ago) / US
Nfyi.org (7 seconds ago) / US
Rixos-premium-tekirova-hotel-kemer.nochi.com.ua (11 seconds ago) / US
Dksalut.ru (42 seconds ago) / NL
Propertyexpoistanbul.com (33 seconds ago) / TR
Erayuma.com (13 seconds ago) / US
Domain Informations
Coherus.com lookup results from whois.godaddy.com server:
- Domain created: 2012-04-18T18:09:52Z
- Domain updated: 2022-09-11T21:40:17Z
- Domain expires: 2026-04-18T18:09:52Z 1 Year, 201 Days left
- Website age: 12 Years, 163 Days
- Registrar Domain ID: 1714336951_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- CLARK.NS.CLOUDFLARE.COM
- DORTHY.NS.CLOUDFLARE.COM
Network
- inetnum : 141.193.213.0 - 141.193.213.255
- name : WPENG
- handle : NET-141-193-213-0-1
- status : Direct Allocation
- created : 2020-03-20
- changed : 2020-07-14
Owner
- organization : WPEngine, Inc.
- handle : WPENG
- address : Array,Austin,TX,78701,US
Abuse
- handle : ABUSE7875-ARIN
- name : Abuse
- phone : +1-512-273-3906
- email : [email protected]
Technical support
- handle : ADMIN7400-ARIN
- name : Admin
- phone : +1-877-973-6446
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 682459 |
namecheap.com | 226280 |
networksolutions.com | 167026 |
tucows.com | 138054 |
publicdomainregistry.com | 86591 |
whois.godaddy.com | 62081 |
enomdomains.com | 58049 |
cloudflare.com | 51575 |
namesilo.com | 48435 |
gmo.jp | 46514 |
register.com | 38825 |
fastdomain.com | 38013 |
ionos.com | 33965 |
wildwestdomains.com | 32128 |
name.com | 31938 |
registrar.amazon.com | 30730 |
net.cn | 30663 |
dynadot.com | 28794 |
key-systems.net | 27094 |
Host Informations
Host name | 141.193.213.11 |
IP address | 141.193.213.11 |
Location | United States |
Latitude | 37.751 |
Longitude | -97.822 |
Timezone | America/Chicago |
Port Scanner (IP: 141.193.213.11)
Spam Check (IP: 141.193.213.11) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with coherus.com on Search Engine
Coherus BioSciences - Choice Without Compromise
Coherus BioSciences, Inc. is proud to team up with our UDENYCA ® (pegfilgrastim-cbqv) biomanufacturing partner KBI Biopharma and their parent company JSR Life Sciences to donate $40,000 to the Boulder County Wildfire Fund to support the heroic first responders who helped save the community from the recent Marshall Fire.
Coherus.comDA: 15 PA: 15 MOZ Rank: 16
Coherus
The current areas of focus of Coherus are to promote health-related programs of 501(c) 3 organizations, certain charitable events in support of community health and health education, wellness, scholarships or supporting the education of students to support programmatic activities and scholarships of 501(c) 3 organizations, including hospital foundations.
Grants.coherus.comDA: 18 PA: 17 MOZ Rank: 36
Coherus and Junshi Biosciences Receive Complete Response Letter …
About Coherus BioSciences. Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to resubmit a BLA for toripalimab for ...
Investors.coherus.comDA: 21 PA: 50 MOZ Rank: 48
COVERAGE HOME - Coherus COMPLETE
Access to Commercial, Medicare, Medicaid, or other Government Insurance Coverage Begins Here
Coheruscomplete.comDA: 23 PA: 7 MOZ Rank: 33
About Coherus - UDENYCA®
At Coherus, we manufacture UDENYCA® with a commitment to high quality, not high cost. Our promise. To offer those in need, whose viability depends on it—patients, healthcare professionals, institutions, and payers—the opportunity to choose the healthcare that will benefit patients the most. Coherus has brought to market a new standard of competition, embracing change and …
Udenyca.comDA: 11 PA: 15 MOZ Rank: 30
Coherus
Enter the email address you registered with and click SUBMIT. You will be sent an email with instructions pertaining to your account and password.
Grants.coherus.comDA: 18 PA: 22 MOZ Rank: 45
Stockwatch
Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved products. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to resubmit a BLA for toripalimab for the treatment ...
Stockwatch.comDA: 18 PA: 44 MOZ Rank: 68
Coherus Biosciences Terminates Deal With Innovent for Avastin …
In Coherus Biosciences' earnings conference call for the first quarter (Q1) of 2022, the company announced it has discontinued development of a bevacizumab biosimilar candidate (CHS-305; IBI-305; Byvasda). Coherus entered into a license agreement with Innovent Biologics for the candidate in January 2020. Under the partnership, Coherus was to have the …
Centerforbiosimilars.comDA: 28 PA: 50 MOZ Rank: 43
Junshi Biosciences and Coherus Receive Complete Response Letter …
Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to resubmit a BLA for toripalimab for the treatment of advanced NPC ...
Ca.sports.yahoo.comDA: 19 PA: 50 MOZ Rank: 91
-$0.60 EPS Expected for Coherus BioSciences, Inc. (NASDAQ:CHRS) …
The biotechnology company reported ($0.60) earnings per share for the quarter, topping the consensus estimate of ($0.61) by $0.01. The company had revenue of $73.37 million for the quarter ...
Defenseworld.netDA: 20 PA: 50 MOZ Rank: 41
Coherus BioSciences Reports First Quarter 2022 Results
Coherus BioSciences, Inc. Reconciliation of GAAP Net Loss to Non-GAAP Net Loss (1) (in thousands, except share and per share data) (unaudited) Three Months Ended March 31, 2022 2021 GAAP net loss ...
Globenewswire.comDA: 21 PA: 50 MOZ Rank: 40
Junshi Biosciences and Coherus Receive Complete Response Letter …
About Coherus BioSciences Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to resubmit a BLA for toripalimab for the …
Financialpost.comDA: 17 PA: 50 MOZ Rank: 39
Coherus Highlights Anticipated New Product Launches and …
About Coherus BioSciences Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In ...
Finance.yahoo.comDA: 17 PA: 50 MOZ Rank: 97
2022-05-05 | NDAQ:CHRS | Press Release | Coherus BioSciences Inc.
About Coherus BioSciences. Coherus is a commercial stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified commercial portfolio of FDA-approved products. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to ...
Stockhouse.comDA: 14 PA: 50 MOZ Rank: 37
Junshi Biosciences and Coherus Announce PD-1 Inhibitor …
About Coherus BioSciences. Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. A biologics license application for toripalimab for ...
Financialpost.comDA: 17 PA: 50 MOZ Rank: 36
CHRS – Stock quote for Coherus BioSciences Inc – MSN Money
Coherus BioSciences (NASDAQ:CHRS) Price Target Cut to $15.00. ETF Daily News 3 days ago.
Msn.comDA: 11 PA: 35 MOZ Rank: 61
2022-05-11 | NDAQ:CHRS | Press Release | Coherus BioSciences Inc.
About Coherus BioSciences. Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved products. In 2021, Coherus in-licensed toripalimab, an anti-PD-1 antibody, in the United States and Canada. Coherus plans to resubmit a BLA for ...
Stockhouse.comDA: 14 PA: 50 MOZ Rank: 34
Coherus BioSciences (CHRS) Q1 2022 Earnings Call Transcript
Research and development expenses for the first quarter of 2022 were $82.9 million, compared to $203.5 million for the same period in 2021. This year's first quarter included a $35 million payment ...
Nasdaq.comDA: 14 PA: 50 MOZ Rank: 98
Junshi Biosciences and Coherus Announce PD-1 Inhibitor
About Coherus BioSciences. Coherus is a commercial stage biopharmaceutical company building a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. In ...
Globenewswire.comDA: 21 PA: 50 MOZ Rank: 32
Coherus BioSciences Announces New Employment Inducement …
Coherus BioSciences Announces New Employment Inducement Grants. 2022-05-03 21:45 ET - News Release. The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company's board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select …
Stockwatch.comDA: 18 PA: 44 MOZ Rank: 81
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
sitrogroup.com | joker.com | 167 Days |
lateefahsimon.com | godaddy.com | 337 Days |
stoprocess.com | onlinenic.com | 1 Year, 3 Days |
innsofmendocino.com | networksolutions.com | 117 Days |
unwrap3d.com | namecheap.com | 1 Year, 186 Days |
elmafidesi.com | godaddy.com | 331 Days |